SONOMA PHARMACEUTICALS, INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SONOMA PHARMACEUTICALS, INC. stock issued during period, value, other for the quarter ending 2026-06-30 was $3.48M.
- SONOMA PHARMACEUTICALS, INC. stock issued during period, value, other for the quarter ending 2023-06-30 was -$5.00K.
- SONOMA PHARMACEUTICALS, INC. stock issued during period, value, other for the quarter ending 2021-12-31 was $662.00K.
- SONOMA PHARMACEUTICALS, INC. stock issued during period, value, other for fiscal 2023 was $2.87M, a 62.03% decline from fiscal 2022.
- SONOMA PHARMACEUTICALS, INC. stock issued during period, value, other for fiscal 2022 was $7.55M.
- SONOMA PHARMACEUTICALS, INC. stock issued during period, value, other for fiscal 2013 was $51.00K.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2026-06-30 | $3.48M 10-Q · filed 2026-08-06 | |
| 2023-06-30 | -$5.00K 10-Q · filed 2023-11-13 | |
| 2023-03-31 | $2.87M 10-K · filed 2023-06-21 | |
| 2022-03-31 | $7.55M 10-K · filed 2023-06-21 | |
| 2021-12-31 | $662.00K 10-Q · filed 2023-02-14 | |
| 2013-03-31 | $51.00K 10-K · filed 2014-06-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |